These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24719424)

  • 1. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.
    Du L; Zhao G; Yang Y; Qiu H; Wang L; Kou Z; Tao X; Yu H; Sun S; Tseng CT; Jiang S; Li F; Zhou Y
    J Virol; 2014 Jun; 88(12):7045-53. PubMed ID: 24719424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.
    Ohnuma K; Haagmans BL; Hatano R; Raj VS; Mou H; Iwata S; Dang NH; Bosch BJ; Morimoto C
    J Virol; 2013 Dec; 87(24):13892-9. PubMed ID: 24067970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.
    Raj VS; Smits SL; Provacia LB; van den Brand JM; Wiersma L; Ouwendijk WJ; Bestebroer TM; Spronken MI; van Amerongen G; Rottier PJ; Fouchier RA; Bosch BJ; Osterhaus AD; Haagmans BL
    J Virol; 2014 Feb; 88(3):1834-8. PubMed ID: 24257613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
    Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
    Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
    Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
    Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L
    Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
    Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
    Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
    Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
    Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
    Wan Y; Shang J; Sun S; Tai W; Chen J; Geng Q; He L; Chen Y; Wu J; Shi Z; Zhou Y; Du L; Li F
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.
    Du L; Zhao G; Kou Z; Ma C; Sun S; Poon VK; Lu L; Wang L; Debnath AK; Zheng BJ; Zhou Y; Jiang S
    J Virol; 2013 Sep; 87(17):9939-42. PubMed ID: 23824801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
    Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
    mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein.
    Zhou H; Chen Y; Zhang S; Niu P; Qin K; Jia W; Huang B; Zhang S; Lan J; Zhang L; Tan W; Wang X
    Nat Commun; 2019 Jul; 10(1):3068. PubMed ID: 31296843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.
    Du L; Kou Z; Ma C; Tao X; Wang L; Zhao G; Chen Y; Yu F; Tseng CT; Zhou Y; Jiang S
    PLoS One; 2013; 8(12):e81587. PubMed ID: 24324708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
    Choi JH; Woo HM; Lee TY; Lee SY; Shim SM; Park WJ; Yang JS; Kim JA; Yun MR; Kim DW; Kim SS; Zhang Y; Shi W; Wang L; Graham BS; Mascola JR; Wang N; McLellan JS; Lee JY; Lee H
    PLoS One; 2020; 15(5):e0232757. PubMed ID: 32384116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
    Chen Y; Lu S; Jia H; Deng Y; Zhou J; Huang B; Yu Y; Lan J; Wang W; Lou Y; Qin K; Tan W
    Emerg Microbes Infect; 2017 May; 6(5):e37. PubMed ID: 28536429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.
    van Doremalen N; Miazgowicz KL; Milne-Price S; Bushmaker T; Robertson S; Scott D; Kinne J; McLellan JS; Zhu J; Munster VJ
    J Virol; 2014 Aug; 88(16):9220-32. PubMed ID: 24899185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.